1. Home
  2. SSD vs PRAX Comparison

SSD vs PRAX Comparison

Compare SSD & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simpson Manufacturing Company Inc.

SSD

Simpson Manufacturing Company Inc.

HOLD

Current Price

$193.98

Market Cap

7.9B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$263.71

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSD
PRAX
Founded
1956
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SSD
PRAX
Price
$193.98
$263.71
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$214.75
$572.13
AVG Volume (30 Days)
246.1K
427.5K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
0.61%
N/A
EPS Growth
8.42
N/A
EPS
2.13
N/A
Revenue
$2,332,808,000.00
N/A
Revenue This Year
$3.82
N/A
Revenue Next Year
$5.57
$7,758.26
P/E Ratio
$90.93
N/A
Revenue Growth
4.51
N/A
52 Week Low
$151.38
$37.25
52 Week High
$211.98
$366.52

Technical Indicators

Market Signals
Indicator
SSD
PRAX
Relative Strength Index (RSI) 58.55 39.24
Support Level $163.08 $157.29
Resistance Level $197.70 $342.62
Average True Range (ATR) 4.78 21.68
MACD 0.43 -6.71
Stochastic Oscillator 86.21 20.77

Price Performance

Historical Comparison
SSD
PRAX

About SSD Simpson Manufacturing Company Inc.

Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: